UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________________________________________________________________

FORM 8-K 
______________________________________________________________________________________________________

CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
November 15, 2016
Date of Report (Date of earliest event reported) 
______________________________________________________________________________________________________
Penumbra, Inc.
(Exact name of registrant as specified in its charter)
______________________________________________________________________________________________________


Delaware
001-37557
05-0605598
(State or other jurisdiction of incorporation or organization)
(Commission File No.)
(I.R.S. employer identification number)
One Penumbra Place
Alameda, CA 94502
(Address of principal executive offices, including zip code)
 
(510) 748-3200
(Registrant’s telephone number, including area code) 
______________________________________________________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions: 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 
(b) On November 15, 2016, Kevin Sullivan notified Penumbra, Inc. (the Company) of his decision to resign from the Board of Directors of the Company (the Board) and the Nominating and Corporate Governance Committee of the Board for personal health reasons, effective immediately. The decision by Mr. Sullivan was not a result of any disagreement with the Company or the Board.







SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Penumbra, Inc.
 
 
 
Date: November 18, 2016
By:
/s/ Sri Kosaraju
 
 
Sri Kosaraju
 
 
Chief Financial Officer and Head of Strategy